PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32041439-11	2020	Immunoblotting experiments revealed that sulforaphane and WE reduced translocation of NF-kappaBp65 into the nucleus and phosphorylation of IkappaBalpha in the cytosol.	sulforaphane	41-53	NFKB inhibitor alpha	Homo sapiens	139-151	
24747121-6	2014	Pretreatment with sulforaphane significantly attenuated nuclear localization, DNA binding and the transcriptional activity of NF-kappaB through inhibition of phosphorylation and subsequent degradation of IkappaBalpha in MCF-10A cells stimulated with TPA.	sulforaphane	18-30	NFKB inhibitor alpha	Homo sapiens	204-216	
18248854-6	2008	The intracellular GSH levels in SFN-treated ECs were observed to be reduced, the time course coincident with the suppression of P65 translocation and IkappaB-alpha degradation.	sulforaphane	32-35	NFKB inhibitor alpha	Homo sapiens	150-163	
15856023-0	2005	Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells.	sulforaphane	68-80	NFKB inhibitor alpha	Homo sapiens	99-111	
15856023-9	2005	In addition, treatment with SFN and PEITC potently inhibited phosphorylation of both IKKbeta and IKKalpha and significantly inhibited the in vitro phosphorylation of IkappaBalpha mediated by IKKbeta.	sulforaphane	28-31	NFKB inhibitor alpha	Homo sapiens	166-178